Since the ideal risk-classification model for risk of AKI is currently being studied in clinical practice, it is necessary to make an effort to analyze potential biomarkers which are available for clinical use, such as NGAL, and [TIMP-2] × [IGFBP7] as AKI risk factors. Here, TIMP2 is linked to acute kidney injury.